Home > Insider Trading > Filing (0001209191-12-037910)

Filing Details

Accession Number:: 0001209191-12-037910
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-07-12 10:58:12
Reporting Period:: 2012-07-10

Filing Date:: 2012-07-12
Accepted Time:: 2012-07-12 10:58:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1400431	Patheon Inc	PTI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1327010	R Alexander Castaldi	450 Lexington Avenue, 31St Floor New York NY 10017	No	No	Yes	No
1404208	Daniel Agroskin	450 Lexingon Avenue, 31St Floor New York NY 10017	Yes	No	Yes	No
1518446	Jll Patheon Holdings Llc	450 Lexington Avenue, 31St Floor New York NY 10017	No	No	Yes	No
1518967	Jll Associates V (Patheon), L.p.	450 Lexington Avenue, 31St Floor New York NY 10017	No	No	Yes	No
1518968	Jll Partners Associates Gp V (Patheon), Ltd.	450 Lexington Avenue, 31St Floor New York NY 10017	No	No	Yes	No
1518969	Jll Partners Fund V (Patheon), L.p.	450 Lexington Avenue, 31St Floor New York NY 10017	No	No	Yes	No
1518970	Jll Patheon Holdings, Cooperatief U.a.	C/O Jll Partners, Inc. 450 Lexington Avenue, 31St Floor New York NY 10017	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Restricted Voting Shares	Acquisiton	2012-07-10	17,000	$2.66	72,196,681	No	4	P	Direct
Restricted Voting Shares	Acquisiton	2012-07-11	6,200	$2.67	72,202,881	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price, as converted from C$2.72 using the closing rate of exchange from Reuters on July 10, 2012. These shares were purchased in multiple transactions at prices ranging from $2.63 to $2.67, as converted from C$2.69 to C$2.73 using the closing rate of exchange from Reuters on July 10, 2012. The Reporting Persons undertake to provide to Patheon Inc., any security holder of Patheon Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
This report is filed jointly by JLL Patheon Holdings, Cooperatief U.A. ("JLL CoOp"); JLL Patheon Holdings, LLC; JLL Partners Fund V (Patheon), L.P.; JLL Associates V (Patheon), L.P.; JLL Associates G.P. V (Patheon), Ltd. ("JLL Limited"); Paul S. Levy; Daniel Agroskin; Nicholas O'Leary; Eugene Hahn; Michael J. Schwartz; Frank J. Rodriguez; Alexander R. Castaldi; Kevin T. Hammond; Michel Lagarde; Thomas Taylor; and Brett N. Milgrim (each, a "Reporting Person" and, collectively, the "Reporting Persons") in connection with their respective direct or indirect relationships with Patheon Inc. (the "Company").
JLL Limited is the sole general partner of JLL Associates V (Patheon), L.P., which is the sole general partner of JLL Partners Fund V (Patheon), L.P., which in turn is the sole member of JLL Patheon Holdings, LLC. JLL Patheon Holdings, LLC is the 99% owner and controlling member of JLL CoOp. The following Reporting Persons serve on the board of directors of JLL Limited: Paul S. Levy; Daniel Agroskin; Nicholas O'Leary; Thomas Taylor; Eugene Hahn; Michael J. Schwartz; Frank J. Rodriguez; Alexander R. Castaldi; Kevin T. Hammond; Michel Lagarde; and Brett N. Milgrim. Mr. Agroskin is also a managing director of JLL CoOp.
JLL CoOp is the direct beneficial owner of 72,202,881 restricted voting shares (the "Restricted Voting Shares") of the Company. Each Reporting Person other than JLL CoOp may be deemed to be the indirect beneficial owner of 72,202,881 Restricted Voting Shares, however, each Reporting Person, other than JLL CoOp, disclaims beneficial ownership of these securities except to the extent of such Reporting Person's pecuniary interest therein, and this report shall not be deemed an admission that any of these reporting persons is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is converted from C$2.72 using the closing rate of exchange from Reuters on July 11, 2012.